NNOX Share Price Performance
US$3.45
-2.71 (-43.99%)
55.5% undervalued intrinsic discount
US$7.75
Fair Value
Price US$3.45
AnalystConsensusTarget US$7.75
AnalystLowTarget US$6.00
AnalystHighTarget US$10.00
Fair ValueUS$7.75
Share Pricen/a
Nano-X Imaging Ltd. Stock Price
- 3 Narratives written by author
- 0 Comments on narratives written by author
- 73 Fair Values set on narratives written by author
NNOX Community Narratives
AN
Fair Value US$7.75 55.5% undervalued intrinsic discount
Digital Diagnostics And AI Will Open Global Markets
0users have liked this narrative
0users have commented on this narrative
52users have followed this narrative
AN
Fair Value US$6 42.5% undervalued intrinsic discount
Rising Regulatory Hurdles Will Test Digital Imaging But Allow Revival
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
Fair Value US$10 65.5% undervalued intrinsic discount
Global Aging And Digitalization Will Accelerate Imaging Adoption
0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
Global Aging And Digitalization Will Accelerate Imaging Adoption
Key Takeaways Rapid digital ecosystem growth, early-career engagement, and mobile imaging offerings set the stage for widespread adoption and entrenched positioning in both mature and emerging healthcare markets. Accelerating AI partnerships, B2B2C models, and demand for preventative care drive operating leverage, recurring revenue streams, and a structurally more profitable business model.Read more
0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
AN
US$10
65.5% undervalued intrinsic discount
AnalystHighTarget Fair Value
Revenue growth
80.38% p.a.
Profit Margin
20.25%
Future PE
70.21x
Share price in 2028
US$11.89
Digital Diagnostics And AI Will Open Global Markets
Key Takeaways Global expansion and scalable manufacturing are set to boost long-term revenue growth, increase market share, and drive sustainable margin improvements. Innovative AI-enabled, cost-effective imaging offerings are positioned to expand addressable markets and generate new high-margin recurring revenue streams.Read more
0users have liked this narrative
0users have commented on this narrative
52users have followed this narrative
AN
US$7.75
55.5% undervalued intrinsic discount
AnalystConsensusTarget Fair Value
Revenue growth
82.8% p.a.
Profit Margin
5.39%
Future PE
196.41x
Share price in 2028
US$9.22
Rising Regulatory Hurdles Will Test Digital Imaging But Allow Revival
Key Takeaways Regulatory hurdles, high R&D costs, and doubts about clinical efficacy may delay adoption and keep revenue and margin improvements slower than expected. AI integration and global expansion offer growth potential, but volatile earnings, compliance risks, and healthcare budget constraints pose ongoing challenges.Read more
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
US$6
42.5% undervalued intrinsic discount
AnalystLowTarget Fair Value
Revenue growth
61.14% p.a.
Profit Margin
5.39%
Future PE
221.97x
Share price in 2028
US$7.14
Recently Updated Narratives
AN
Rising Regulatory Hurdles Will Test Digital Imaging But Allow Revival
Fair Value: US$6 42.5% undervalued intrinsic discount
0 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
Global Aging And Digitalization Will Accelerate Imaging Adoption
Fair Value: US$10 65.5% undervalued intrinsic discount
2 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
Digital Diagnostics And AI Will Open Global Markets
Fair Value: US$7.75 55.5% undervalued intrinsic discount
52 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Nano-X Imaging Ltd. Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
- -0.87
- -100.88%
- -468.29%
- 2.0%
About NNOX
- Founded
- 2011
- Employees
- 165
- CEO
- WebsiteView website
Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. It provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. The company’s solutions include Nanox Multi Source System comprising Nanox.ARC, a medical tomographic imaging system incorporating its digital X-ray source; and Nanox. CLOUD, a platform which employs a matching engine to match medical images to radiologists that provides image repository, connectivity to diagnostic assistive AI systems, billing, and reporting. It also offers Nanox.MARKETPLACE, which connects imaging facilities with radiologists and enables radiologists to provide and obtain remote interpretations of imaging data; Nanox.CONNECT to receive local regulatory approvals and explore and evaluate the business model and the potential service; artificial intelligence (AI)-based software imaging solutions to hospitals, health maintenance organizations, integrated delivery networks, pharmaceutical companies, and insurers that are designed to identify or predict undiagnosed or underdiagnosed medical conditions through the mining of data included in images of existing computed tomography scans; Teleradiology Services, which provide imaging interpretation services for radiology practices, hospitals, medical clinics, diagnostic imaging centers and mobile imaging service providers, urgent care facilities, and multi-specialty physician groups. The company was founded in 2011 and is headquartered in Petah Tikva, Israel.
